New Data Confirms Bioequivalence of Relexxii® and Concerta® in Healthy Adults(1)
Alora Pharmaceuticals, LLC, the parent company of Vertical Pharmaceuticals, LLC, a leading pharmaceutical company committed to advancing access to high-quality therapies, announces the publication of a pivotal pharmacokinetic (PK) study in a peer-reviewed journal demonstrating bioequivalence between its extended-release formulation of Relexxii (methylphenidate hydrochloride extended-release tablets) and the reference product, Concerta®(methylphenidate hydrochloride extended-release tablets)commonly prescribed […]